<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Fortrea Holdings Inc. — News on 6ix</title>
<link>https://6ix.com/company/fortrea-holdings-inc</link>
<description>Latest news and press releases for Fortrea Holdings Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/fortrea-holdings-inc" rel="self" type="application/rss+xml" />
<item>
<title>Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-date-for-first-quarter-2026-financial-results-and-conference-call-1</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-date-for-first-quarter-2026-financial-results-and-conference-call-1</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>DURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today</description>
</item>
<item>
<title>Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-unveils-fortrea-intelligent-technologytm-to-help-sponsors-and-sites-run-smarter-more-integrated-trials</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-unveils-fortrea-intelligent-technologytm-to-help-sponsors-and-sites-run-smarter-more-integrated-trials</guid>
<pubDate>Tue, 07 Apr 2026 04:00:00 GMT</pubDate>
<description>AI-enhanced suite of solutions features new and improved technology to empower efficiency, confidence and quality Highlights: Designed to transform clinical</description>
</item>
<item>
<title>Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-reports-fourth-quarter-and-full-year-2025-results-issues-full-year-2026-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-reports-fourth-quarter-and-full-year-2025-results-issues-full-year-2026-guidance</guid>
<pubDate>Thu, 26 Feb 2026 05:00:00 GMT</pubDate>
<description>Revenue and Adjusted EBITDA results delivered in line with stated full-year targetsFull‑year cost savings exceeded previously communicated targets Highlights:</description>
</item>
<item>
<title>Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services</guid>
<pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
<description>Adds to executive focus on early clinical development and deepens medical and scientific partnership with clientsDURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who previously served as both Fortrea’s chief medical officer (CMO) and president of Clinical Pharmacology Services (CPS) is now dedicated to his CMO responsibilities, namely me</description>
</item>
<item>
<title>Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-date-fourth-quarter-130800902</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-date-fourth-quarter-130800902</guid>
<pubDate>Thu, 29 Jan 2026 13:08:00 GMT</pubDate>
<description>DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online a</description>
</item>
<item>
<title>Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-updated-presentation-time-162400467</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-updated-presentation-time-162400467</guid>
<pubDate>Fri, 09 Jan 2026 16:24:00 GMT</pubDate>
<description>DURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on Tuesday, January 13, 2026, at the J.P. Morgan Annual Healthcare Conference (San Francisco). CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the conference. The live webcast and replay can be accessed through the “Events” section of Fortrea’s Investor Re</description>
</item>
<item>
<title>Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-present-upcoming-j-p-120000189</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-present-upcoming-j-p-120000189</guid>
<pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
<description>DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that CEO...</description>
</item>
<item>
<title>Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-grant-inducement-awards-under-nasdaq-listing-rule-5635c4-2025-12-10</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-grant-inducement-awards-under-nasdaq-listing-rule-5635c4-2025-12-10</guid>
<pubDate>Wed, 10 Dec 2025 05:00:00 GMT</pubDate>
<description>DURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the</description>
</item>
<item>
<title>SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/sctbio-and-fortrea-forge-strategic-collaboration-accelerate-cell-and-gene-therapy</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/sctbio-and-fortrea-forge-strategic-collaboration-accelerate-cell-and-gene-therapy</guid>
<pubDate>Thu, 04 Dec 2025 05:00:00 GMT</pubDate>
<description>PRAGUE, Czech Republic and DURHAM, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) -- SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based</description>
</item>
<item>
<title>Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-present-upcoming-citi-and-evercore-healthcare-conferences-2025-11-25</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-present-upcoming-citi-and-evercore-healthcare-conferences-2025-11-25</guid>
<pubDate>Tue, 25 Nov 2025 05:00:00 GMT</pubDate>
<description>DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that chief</description>
</item>
<item>
<title>Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-completes-757-million-senior-notes-tender-offer-utilizing-cash-hand-2025-11</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-completes-757-million-senior-notes-tender-offer-utilizing-cash-hand-2025-11</guid>
<pubDate>Mon, 24 Nov 2025 05:00:00 GMT</pubDate>
<description>DURHAM, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced</description>
</item>
<item>
<title>Fortrea Appoints Agnieszka Gallagher as General Counsel</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-appoints-agnieszka-gallagher-general-counsel-2025-11-17</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-appoints-agnieszka-gallagher-general-counsel-2025-11-17</guid>
<pubDate>Mon, 17 Nov 2025 05:00:00 GMT</pubDate>
<description>DURHAM, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced</description>
</item>
<item>
<title>Fortrea Reports Third Quarter 2025 Results</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-reports-third-quarter-2025-results-2025-11-05</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-reports-third-quarter-2025-results-2025-11-05</guid>
<pubDate>Wed, 05 Nov 2025 05:00:00 GMT</pubDate>
<description>For the three months ended September 30, 2025, from continuing operations: Revenues of $701.3 millionGAAP net loss of $(15.9) millionAdjusted EBITDA of $50.7</description>
</item>
<item>
<title>Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-tender-offer-75744000-aggregate-purchase-price-outstanding-debt</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-tender-offer-75744000-aggregate-purchase-price-outstanding-debt</guid>
<pubDate>Mon, 20 Oct 2025 04:00:00 GMT</pubDate>
<description>DURHAM, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today</description>
</item>
<item>
<title>Fortrea Announces Date for Third Quarter 2025 Financial Results and Conference Call</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-date-third-quarter-2025-financial-results-and-conference-call-2025</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-date-third-quarter-2025-financial-results-and-conference-call-2025</guid>
<pubDate>Wed, 15 Oct 2025 04:00:00 GMT</pubDate>
<description>DURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced</description>
</item>
<item>
<title>Fortrea Appoints William Sharbaugh to Board of Directors</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-appoints-william-sharbaugh-board-directors-2025-09-22</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-appoints-william-sharbaugh-board-directors-2025-09-22</guid>
<pubDate>Mon, 22 Sep 2025 04:00:00 GMT</pubDate>
<description>DURHAM, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today</description>
</item>
<item>
<title>Fortrea Reports Second Quarter 2025 Results</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-reports-second-quarter-2025-results-2025-08-06</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-reports-second-quarter-2025-results-2025-08-06</guid>
<pubDate>Wed, 06 Aug 2025 04:00:00 GMT</pubDate>
<description>For the three months ended June 30, 2025, from continuing operations: Revenues of $710.3 millionGAAP net loss of $(374.9) million, inclusive of a non-cash</description>
</item>
<item>
<title>Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-appoints-tracy-krumme-senior-vice-president-investor-relations-2025-08-06</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-appoints-tracy-krumme-senior-vice-president-investor-relations-2025-08-06</guid>
<pubDate>Tue, 05 Aug 2025 04:00:00 GMT</pubDate>
<description>DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment</description>
</item>
<item>
<title>Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-date-second-quarter-2025-financial-results-and-conference-call-2025</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/fortrea-announces-date-second-quarter-2025-financial-results-and-conference-call-2025</guid>
<pubDate>Wed, 16 Jul 2025 04:00:00 GMT</pubDate>
<description>DURHAM, N.C., July 16, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced</description>
</item>
<item>
<title>Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA</title>
<link>https://6ix.com/company/fortrea-holdings-inc/news/avant-technologies-and-jv-partner-ainnova-complete-pivotal-meeting-with-us-fda</link>
<guid isPermaLink="true">https://6ix.com/company/fortrea-holdings-inc/news/avant-technologies-and-jv-partner-ainnova-complete-pivotal-meeting-with-us-fda</guid>
<pubDate>Tue, 15 Jul 2025 12:00:00 GMT</pubDate>
<description>Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the completion of its milestone meeting with the U.S. Food and Drug Administration (FDA). The pre-submission meeting allowed Ainnova and its Contract Research Organization (CRO), Fortrea, to present and discuss Ainnova's planned clinical tr</description>
</item>
</channel>
</rss>